Virbac SA
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific. The company offers a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. I… Read more
Virbac SA (VRBCF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.026x
Based on the latest financial reports, Virbac SA (VRBCF) has a cash flow conversion efficiency ratio of 0.026x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($27.65 Million) by net assets ($1.07 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Virbac SA - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Virbac SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Virbac SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Virbac SA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Liberty Latin America Ltd Class C
NASDAQ:LILAK
|
0.154x |
|
China Conch Venture Holdings Limited
PINK:CCVTF
|
0.018x |
|
Kumho Petro Chemical
KO:011780
|
0.034x |
|
TMC the metals company Inc
NASDAQ:TMC
|
0.283x |
|
Joincare Pharmaceutical Group Industry Co Ltd
SHG:600380
|
0.045x |
|
Pci-Suntek Technology Co Ltd
SHG:600728
|
0.008x |
|
Beijing Xinleineng Technology Co Ltd
SHE:300593
|
-0.023x |
|
PCCOF
PINK:PCCOF
|
0.043x |
Annual Cash Flow Conversion Efficiency for Virbac SA (2002–2024)
The table below shows the annual cash flow conversion efficiency of Virbac SA from 2002 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.04 Billion | $204.22 Million | 0.196x | +49.71% |
| 2023-12-31 | $909.92 Million | $118.96 Million | 0.131x | +10.81% |
| 2022-12-31 | $838.98 Million | $98.98 Million | 0.118x | -34.14% |
| 2021-12-31 | $725.19 Million | $129.90 Million | 0.179x | -1.01% |
| 2020-12-31 | $657.18 Million | $118.92 Million | 0.181x | -24.12% |
| 2019-12-31 | $551.88 Million | $131.61 Million | 0.238x | +41.41% |
| 2018-12-31 | $495.87 Million | $83.62 Million | 0.169x | -25.10% |
| 2017-12-31 | $478.84 Million | $107.81 Million | 0.225x | -17.69% |
| 2016-12-31 | $520.79 Million | $142.45 Million | 0.274x | +185.41% |
| 2015-12-31 | $482.29 Million | $46.22 Million | 0.096x | -39.60% |
| 2014-12-31 | $481.78 Million | $76.45 Million | 0.159x | -10.70% |
| 2013-12-31 | $414.37 Million | $73.63 Million | 0.178x | -27.04% |
| 2012-12-31 | $398.42 Million | $97.03 Million | 0.244x | +23.73% |
| 2011-12-31 | $313.87 Million | $61.78 Million | 0.197x | -29.06% |
| 2010-12-31 | $302.35 Million | $83.90 Million | 0.277x | +1.18% |
| 2009-12-31 | $236.20 Million | $64.78 Million | 0.274x | +30.39% |
| 2008-12-31 | $201.01 Million | $42.28 Million | 0.210x | -23.17% |
| 2007-12-31 | $184.28 Million | $50.45 Million | 0.274x | -7.49% |
| 2006-12-31 | $164.93 Million | $48.81 Million | 0.296x | +32.55% |
| 2005-12-31 | $160.19 Million | $35.76 Million | 0.223x | -29.10% |
| 2004-12-31 | $131.17 Million | $41.30 Million | 0.315x | +255.04% |
| 2003-12-31 | $299.60 Million | $26.57 Million | 0.089x | -21.47% |
| 2002-12-31 | $273.79 Million | $30.92 Million | 0.113x | -- |